CTI BioPharma Statistics
Total Valuation
IWSH has a market cap or net worth of 3.40 million. The enterprise value is 1.28 million.
| Market Cap | 3.40M |
| Enterprise Value | 1.28M |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IWSH has 20.62 million shares outstanding.
| Current Share Class | 20.62M |
| Shares Outstanding | 20.62M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 27.88% |
| Owned by Institutions (%) | 1.07% |
| Float | 8.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.64 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.34 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.79
| Current Ratio | 19.79 |
| Quick Ratio | 19.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -37.48% and return on invested capital (ROIC) is -26.46%.
| Return on Equity (ROE) | -37.48% |
| Return on Assets (ROA) | -25.51% |
| Return on Invested Capital (ROIC) | -26.46% |
| Return on Capital Employed (ROCE) | -52.10% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -478,500 |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.90% in the last 52 weeks. The beta is 0.53, so IWSH's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +6.90% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.16 |
| Relative Strength Index (RSI) | 54.72 |
| Average Volume (20 Days) | 6,157 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | -454,000 |
| Operating Income | -1.08M |
| Pretax Income | -957,000 |
| Net Income | -957,000 |
| EBITDA | n/a |
| EBIT | -1.08M |
| Earnings Per Share (EPS) | -0.05 |
Balance Sheet
The company has 2.12 million in cash and n/a in debt, giving a net cash position of 2.12 million or 0.10 per share.
| Cash & Cash Equivalents | 2.12M |
| Total Debt | n/a |
| Net Cash | 2.12M |
| Net Cash Per Share | 0.10 |
| Equity (Book Value) | 2.08M |
| Book Value Per Share | 0.10 |
| Working Capital | 2.07M |
Cash Flow
| Operating Cash Flow | -936,000 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IWSH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -28.13% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |